GlobeNewswire Inc | Jan 5, 2022 04:05PM EST

January 05, 2022

Reiterates Fiscal 2022 Guidance for Lifecore

Provides Pro Forma Curation Foods Segment Results and Updates Guidance for Continuing Segment Operations

SANTA MARIA, Calif., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Landec Corporation (Nasdaq: LNDC) (Landec or the Company), a diversified health and wellness company with two operating businesses, Lifecore Biomedical, Inc. ("Lifecore") and Curation Foods, Inc., reported results for the fiscal 2022 second quarter ended November28, 2021. Subsequent to fiscal second quarter end, on December 13, 2021 the Company closed on the sale of its Curation Foods fresh packaged salads and vegetables business (the Eat Smart Disposition) for $73.5 million in cash, subject to certain adjustments. Looking forward, Landec continues to focus on creating shareholder value through strengthening its balance sheet, accelerating growth at Lifecore, and seeking opportunities to optimize its remaining assets.

CEO COMMENTS:We have made great progress in our strategic plan to transform Landec. The divestment of our Eat Smart fresh packaged salad and vegetables business marked an important milestone toward extracting value from our non-core assets within the Curation Foods business and re-orienting the Company around our Lifecore business, commented Dr. Albert Bolles, Chief Executive Officer of Landec Corporation. Lifecore performed well during the second quarter, delivering 7% revenue growth, which we expect to accelerate further in the second half of fiscal 2022, and 26% adjusted EBITDA growth in our Lifecore segment. We will continue to optimize the value of the remaining assets within Curation Foods, while turning our primary focus to Lifecore, which we believe is at an inflection point to drive a multi-year acceleration in growth."

FISCAL SECOND QUARTER 2022 BUSINESS HIGHLIGHTS:

-- Revenues of $129.5 million, pro forma revenues of $43.5 million after adjustment for the Eat Smart Disposition, a pro forma increase of 8.8% year-over-year -- Gross profit of $13.0 million, pro forma gross profit of $14.7 million, a pro forma increase of 8.2% year-over-year -- Net loss of $38.4 million, which includes non-cash goodwill impairment related to the Eat Smart Disposition of $29.1 million and $1.9 million of restructuring and other non-recurring charges such as legal expenses, both net of tax -- Pro forma adjusted EBITDA of $8.3 million, compared to $5.9 million in the prior year period, a pro forma increase of 41.3% year-over-year -- Lifecore segment adjusted EBITDA of $9.1 million, compared to $7.3 million in the prior year period, an increase of 25.6% year-over-year -- Curation Foods segment pro forma adjusted EBITDA of $0.8 million, compared to $0.7 million in the prior year period

Pro forma information gives pro forma effect to the Eat Smart Disposition, as if the Eat Smart Disposition occurred at the beginning of each respective period. See Pro Forma Financial Information at the end of this release for more information regarding the pro forma adjustments related to the Eat Smart Disposition including a reconciliation of pro forma adjusted EBITDA.

FIRST SIX MONTHS FISCAL 2022 BUSINESS HIGHLIGHTS:

-- Revenues of $258.3 million, pro forma revenues of $85.1 million after adjustment for the Eat Smart Disposition, a pro forma increase of 3.8% year-over-year -- Gross profit of $30.5 million, pro forma gross profit of $25.2 million, a pro forma increase of 17.3% year-over-year -- Net loss of $47.9 million, which includes non-cash goodwill impairment related to the Eat Smart Disposition of $29.1 million and $5.0 million of restructuring and other non-recurring charges such as legal expenses, both net of tax -- Pro forma adjusted EBITDA of $10.8 million, compared to $5.1 million in the prior year period, a pro forma increase of 114.0% year-over-year -- Lifecore segment adjusted EBITDA of $11.4 million, compared to $8.7million in the prior year period, an increase of 30.9% year-over-year -- Curation Foods segment pro forma adjusted EBITDA of $3.1 million, compared to $0.7 million in the prior year period

See Pro Forma Financial Information at the end of this release for more information regarding the Pro Forma Adjustments for the Eat Smart Disposition.

FISCAL SECOND QUARTER 2022 RESULTS:Fiscal second quarter 2022 results compared to fiscal second quarter 2021 are as follows:

(Unauditedand inthousands, Three Months Ended Changeexceptper-sharedata) November 28, 2021 November 29, 2020 Amount %Revenues $ 129,492 $ 130,904 $ (1,412 ) (1 ) %Gross 12,992 20,637 (7,645 ) (37 ) %profitNet loss (38,441 ) (13,301 ) (25,140 ) (189 ) %EBITDA* (31,719 ) (8,680 ) (23,039 ) (265 ) %Pro forma 43,452 39,945 3,507 9 %revenues**Pro formagross 14,715 13,601 1,114 8 %profit**Pro formaadjusted 8,304 5,875 2,429 41 %EBITDA**

* See Non-GAAP Financial Information at the end of this release for more information and for a reconciliation of certain financial information.** Pro forma information gives pro forma effect to the Eat Smart Disposition, as if the Eat Smart Disposition occurred at the beginning of each respective period. See Pro Forma Financial Information at the end of this release for more information regarding the pro forma adjustments related to the Eat Smart Disposition including a reconciliation of pro forma EBITDA .

Revenues decreased $1.4 million year-over-year, which was primarily a result of a 2.9% decrease in Curation Foods revenues partially offset by a 7.4% increase in Lifecore segment revenues. Pro forma revenues increased $3.5 million or 8.8% year-over-year, which was primarily a result of a 10.6% increase in Curation Foods pro forma segment revenues and a 7.4% increase in Lifecore segment revenues, each as described below.

Gross profit decreased $7.6 million year-over-year, while pro forma gross profit increased $1.1 million, or 8.2% year-over-year, and pro forma gross profit margin decreased approximately 10 basis points to 33.9% compared to 34.0% in the prior year period.

Net loss increased $25.1 million to a loss of $38.4 million for fiscal second quarter, which includes non-cash goodwill impairment related to the Eat Smart Disposition of $29.1 million, net of tax, and $1.9 million of restructuring and non-recurring charges, net of taxes, related to consolidating and optimizing operations associated with Project SWIFT. This compares to a net loss of $13.3 million in the prior year period, which includes $4.4 million of restructuring and non-recurring charges, net of tax, related to consolidating and optimizing operations associated with Project SWIFT.

Pro forma adjusted EBITDA increased $2.5 million, or 41.3%, year-over-year, to $8.3 million for fiscal second quarter 2022 which excludes restructuring and other non-recurring charges and is pro forma adjusted. This compares to pro forma adjusted EBITDA of $5.9 million in the prior year fiscal second quarter. At the segment level during fiscal second quarter 2022, Lifecore generated $9.1 million in adjusted EBITDA, which represents an increase of $1.9million, or 25.6%, versus the prior year period and Curation Foods generated $0.8 million in pro forma adjusted EBITDA, which represents an increase of $0.1 million versus the prior year period.

SEGMENT RESULTS:

Lifecore Segment:

(Unaudited and Three Months Ended Change Six Months Ended Changein thousands) November 28, November 29, Amount % November 28, November 29, Amount % 2021 2020 2021 2020Revenue: CDMO $ 21,363 $ 18,259 $ 3,104 17 % $ 39,152 $ 34,747 $ 4,405 13 %Fermentation 3,583 4,960 (1,377 ) (28 ) % 7,746 10,277 (2,531 ) (25 ) %Total revenue $ 24,946 $ 23,219 $ 1,727 7 % $ 46,898 $ 45,024 $ 1,874 4 %

Lifecore is the Companys CDMO business focused on product development and manufacturing of sterile injectable products. Lifecore continues to expand its presence in the robust CDMO marketplace by utilizing its specialized capabilities to partner with and provide value added services to biopharmaceutical and medical device companies. Lifecore continues to drive growth and profitability with a focus on building its business development pipeline, maximizing capacity and advancing product commercialization for innovative new therapies that improve patients lives.

In the fiscal second quarter 2022, Lifecore realized total revenues of $24.9 million, or a 7.4% increase versus the prior year period driven by a 17.0% increase in its CDMO business, partially offset by a 27.8% decrease in its fermentation business which is a result of timing of shipments.

Curation Foods Segment:

(Unaudited Three Months Ended Change Six Months Ended Changeand inthousands) November 28, November 29, November 28, November 29, 2021 2020 Amount % 2021 2020 Amount %

Revenue: Freshpackaged $ 88,548 $ 92,423 $ (3,875 ) (4 ) % $ 178,044 $ 188,602 $ (10,558 ) (6 ) %salads andvegetablesAvocado 15,381 14,713 668 5 % 32,343 31,729 614 2 %productsTechnology 617 549 68 12 % 995 1,192 (197 ) (17 ) %Total $ 104,546 $ 107,685 $ (3,139 ) (3 ) % $ 211,382 $ 221,523 $ (10,141 ) (5 ) %revenue

(Unaudited Three Months Ended Change Six Months Ended Changeand inthousands) November 28, November 29, November 28, November 29, 2021 2020 Amount % 2021 2020 Amount %

Pro Forma Revenue:Freshpackaged $ 2,508 $ 1,464 $ 1,044 71 % $ 4,848 $ 3,995 $ 853 21 %salads andvegetablesAvocado 15,381 14,713 668 5 % 32,343 31,729 614 2 %productsTechnology 617 549 68 12 % 995 1,192 (197 ) (17 ) %Total proforma $ 18,506 $ 16,726 $ 1,780 11 % $ 38,186 $ 36,916 $ 1,270 3 %revenue

Pro forma information gives pro forma effect to the Eat Smart Disposition, as if the Eat Smart Disposition occurred at the beginning of each respective period. See Pro Forma Financial Information at the end of this release for more information regarding the pro forma adjustments related to the Eat Smart Disposition, including a reconciliation of pro forma EBITDA.

Curation Foods is the Companys natural food business. The Company continued its focus on execution of Project SWIFT the Company's value creation program that aims to strengthen the Curation Foods business by simplifying the business, improving operating cost structure, and enhancing profitability with a focus on higher margin products. Subsequent to fiscal second quarter end, on December 13, 2021 the Company closed on the Eat Smart Disposition for $73.5 million in cash, subject to certain adjustments.

Curation Foods realized total revenues of $104.5 million for the fiscal second quarter, while pro forma adjusted Curation Foods revenue was $18.5 million for the same period. The total segment pro forma revenues increased 10.6% versus the prior year period, primarily driven by an increase in sales velocity from O Olive (which has historically been included in the fresh packaged salads and vegetables business categorization) and Avocado Products. As a result, the fresh packaged salads and vegetables business pro forma revenue (now representing solely O Olive) increased $1.0 million, or 71%, to $2.5 million. The avocado products business increased $0.7 million or, 4.5%, with revenues of $15.4 million.

CASH FLOW & BALANCE SHEETCash used in operations was $4.3 million for the six month period ended November28, 2021 compared to cash provided by operations of $18.5 million in the prior year period. Cash from investing activities improved $27.7 million versus the prior year period, primarily driven by proceeds from the sale of the Windset investment of $45.1 million. Capital expenditures were $13.0 million for the six month period ended November28, 2021 compared to $7.4 million in the prior year period. Cash used in financing activities was $29.1 million for the six month period ended November28, 2021 driven by payments on the Companys term debt, compared to $22.0 million in the prior year period.

The Company had cash and cash equivalents of $1.1 million as of November28, 2021. Total bank debt net of cash at fiscal second quarter end was $165.1 million, consisting of its line of credit and long-term debt, compared to $192.6 million at fiscal 2021 year end, May 30, 2021. The Company used net proceeds from the Eat Smart Disposition to repay $67.9 million in borrowings under the Companys existing credit agreements, resulting in a pro forma bank debt balance net of cash at November28, 2021 of $97.2 million.

FISCAL 2022 OUTLOOK:The Company is reiterating guidance for its Lifecore segment. Additionally, it is updating its guidance to reflect the Curation Foods EatSmart Disposition on December 13, 2021, and incremental inflationary and supply chain headwind within the remaining Curation Foods business. Revised guidance for Consolidated Landec and Curation Foods segment are provided below with growth figures that are compared to fiscal 2021. Please reference the guidance reconciliation tables at the end of the press release for further detail:

Revenue from continuing operations (full year fiscal 2022):

-- Consolidated Revenues: range of $179 million to $185 million (+4% to +8%) -- Lifecore segment: range of $105 million to $108 million (+7% to +10%) -- Curation Foods segment (fiscal 2022, as reported): range of $261 million to $264 million -- Pro forma Curation Foods segment (fiscal 2022, pro forma for the completion of the Eat Smart Disposition as if it occurred on May 31, 2021): range of $74 million to $77 million (+1% to +5%)

Adjusted EBITDA from continuing operations (full year fiscal 2022):

-- Consolidated: range of $20.5 million to $23 million (+10% to +24%) -- Lifecore segment: range of $26 million to $27 million (+6% to +10%) -- Curation Foods segment (fiscal 2022, as reported): range of ($2) million to ($3) million -- Pro forma Curation Foods segment (fiscal 2022, pro forma for the completion of the Eat Smart Disposition as if it occurred on May 31, 2021): range of $3 million to $4 million (flat to +33%) -- Other (Corporate Expense): range of ($8.0) million to ($8.5) million; reflects a $3.5 million reallocation of corporate expense from the Eat Smart Disposition to the Other segment.

Conference CallThe live webcast can be accessed via Landecs website on the Investor Events & Presentations page. The webcast will be available for 30 days.

Date: Wednesday, January5, 2022

Time: 5:00 p.m. Eastern time (2:00 p.m. Pacific time)

Direct Webcast link: http://ir.Landec.com/events.cfm

To participate in the conference call via telephone, dial toll-free: (877) 407-3982 or (201) 493-6780. Please call the conference telephone number 5-10 minutes prior to the start time so the operator can register your name and organization. If you have any difficulty with the webcast or connecting to the call, please contact ICR at (646) 277-1263.

A replay of the call will be available through Wednesday, January 12, 2022 by calling toll-free: (844) 512-2921 or direct (412) 317-6671, and entering code 13725662.

About Landec CorporationLandec Corporation (Nasdaq: LNDC) is a leading innovator of diversified health and wellness solutions with two operating businesses: Lifecore Biomedical, Inc. and Curation Foods, Inc. Lifecore Biomedical is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of complex sterile injectable pharmaceutical products in syringes and vials. As a leading manufacturer of premium, injectable grade Hyaluronic Acid, Lifecore brings 35 years of expertise as a partner for global and emerging biopharmaceutical and biotechnology companies across multiple therapeutic categories to bring their innovations to market. Curation Foods is focused on innovating and distributing plant-based foods with 100% clean ingredients to retail, club and foodservice channels. Curation Foods brands include Yucatan and Cabo Fresh avocado products and O Olive Oil & Vinegar premium artisan products. For more information about the Company, visit Landecs website at www.landec.com.

Non-GAAP Financial InformationThis press release contains non-GAAP financial information, including with respects to EBITDA, adjusted EBITDA, Lifecore segment adjusted EBITDA, Curation Foods segment adjusted EBITDA, Other segment adjusted EBITDA pro forma adjusted EBITDA and Curation Foods segment adjusted EBITDA. The Company has included reconciliations of these non-GAAP financial measures to their respective most directly comparable financial measures calculated in accordance with GAAP. See the section entitled Non-GAAP Financial Information and Reconciliations in this release for definitions of EBITDA, adjusted EBITDA, Lifecore segment adjusted EBITDA, Curation Foods segment adjusted EBITDA, Other segment adjusted EBITDA, pro forma adjusted EBITDA and Curation Foods segment adjusted EBITDA, and those reconciliations.

The Company has disclosed these non-GAAP financial measures to supplement its consolidated financial statements presented in accordance with GAAP. These non-GAAP financial measures exclude/include certain items that are included in the Companys results reported in accordance with GAAP. Management believes these non-GAAP financial measures provide useful additional information to investors about trends in the Companys operations and are useful for period-over-period comparisons. These non-GAAP financial measures should not be considered in isolation or as a substitute for the comparable GAAP measures. In addition, these non-GAAP financial measures may not be the same as similar measures provided by other companies due to the potential differences in methods of calculation and items being excluded/included. These non-GAAP financial measures should be read in conjunction with the Companys consolidated financial statements presented in accordance with GAAP.

Important Cautions Regarding Forward-Looking StatementsThis press release contains forward-looking statements regarding future events and our future results that are subject to the safe harbor created under the Private Securities Litigation Reform Act of 1995 and other safe harbors under the Securities Act of 1933 and the Securities Exchange Act of 1934. Words such as anticipate, estimate, expect, project, plan, intend, believe, may, might, will, should, can have, likely and similar expressions are used to identify forward-looking statements. All forward-looking statements involve certain risks and uncertainties that could cause actual results to differ materially, including such factors among others, as the timing and expenses associated with operations, the ability to achieve acceptance of the Companys new products in the market place, weather conditions that can affect the supply and price of produce, government regulations affecting our business, the timing of regulatory approvals, uncertainties related to COVID-19 and the impact of our responses to it, the ability to successfully integrate Yucatan Foods into the Curation Foods business, and the mix between domestic and international sales. For additional information about factors that could cause actual results to differ materially from those described in the forward-looking statements, please refer to our filings with the Securities and Exchange Commission, including the risk factors contained in our most recent Quarterly Report on Form 10-Q and Annual Report on Form 10-K. Forward-looking statements represent managements current expectations and are inherently uncertain. Except as required by law, we do not undertake any obligation to update forward-looking statements made by us to reflect subsequent events or circumstances.

LANDEC CORPORATIONCONSOLIDATED CONDENSED BALANCE SHEETS(In thousands, except par value)

November 28, May 30, 2021 2021 (Unaudited) ASSETS Current Assets: Cash and cash equivalents $ 1,091 $ 1,295 Accounts receivable, less allowance for credit losses 65,276 70,013 Inventories 79,433 69,663 Prepaid expenses and other current assets 8,721 7,350 Total Current Assets 154,521 148,321 Investment in non-public company, fair value ? 45,100 Property and equipment, net 179,929 179,559 Operating lease right-of-use assets 11,979 20,827 Goodwill 37,329 69,386 Trademarks/tradenames, net 25,328 25,328 Customer relationships, net 9,799 10,792 Other assets 3,239 3,611 Total Assets $ 422,124 $ 502,924 LIABILITIES AND STOCKHOLDERS? EQUITY Current Liabilities: Accounts payable $ 59,098 $ 47,569 Accrued compensation 7,214 12,304 Other accrued liabilities 9,804 7,996 Current portion of lease liabilities 2,988 3,889 Deferred revenue 1,160 1,130 Line of credit 42,000 29,000 Total Current Liabilities 122,264 101,888 Long-term debt, net 124,194 164,902 Long-term lease liabilities 14,203 23,611 Deferred taxes, net 1,367 6,140 Other non-current liabilities 3,894 3,599 Total Liabilities 265,922 300,140 Stockholders? Equity: Common stock, $0.001 par value; 50,000 sharesauthorized; 29,481 and 29,333 shares 29 29 issued and outstanding at November 28, 2021 and May30, 2021, respectivelyAdditional paid-in capital 166,327 165,533 Retained earnings (accumulated deficit) (9,338 ) 38,580 Accumulated other comprehensive loss (816 ) (1,358 )Total Stockholders? Equity 156,202 202,784 Total Liabilities and Stockholders? Equity $ 422,124 $ 502,924

LANDEC CORPORATIONCONSOLIDATED CONDENSED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME(Unaudited)(In thousands, except per share amounts)

Three Months Ended Six Months Ended November November November November 28, 2021 29, 2020 28, 2021 29, 2020Product sales $ 129,492 $ 130,904 $ 258,280 $ 266,547 Cost of product sales 116,500 110,267 227,769 229,564 Gross profit 12,992 20,637 30,511 36,983 Operating costs and expenses:Research and development 2,718 2,572 5,544 5,080 Selling, general and 13,835 16,106 29,774 34,009 administrativeImpairment of goodwill 32,057 ? 32,057 ? Legal settlement charge ? 1,763 ? 1,763 Restructuring costs 1,412 1,662 3,974 10,066 Total operating costs and 50,022 22,103 71,349 50,918 expensesOperating loss (37,030 ) (1,466 ) (40,838 ) (13,935 ) Dividend income ? 281 ? 563 Interest income 19 10 46 18 Interest expense, net (4,333 ) (3,039 ) (12,250 ) (6,148 )Other (expense) income, 79 (11,787 ) 188 (11,808 )netNet loss before tax (41,265 ) (16,001 ) (52,854 ) (31,310 )Income tax benefit 2,824 2,700 4,936 7,009 Net loss $ (38,441 ) $ (13,301 ) $ (47,918 ) $ (24,301 ) Diluted net loss per $ (1.30 ) $ (0.45 ) $ (1.63 ) $ (0.83 )common share Shares used in diluted per 29,471 29,280 29,448 29,261 share computation

LANDEC CORPORATIONCONSOLIDATED STATEMENTS OF CASH FLOWS(Unaudited and in thousands)

Six Months Ended November November 28, 2021 29, 2020Cash flows from operating activities: Net loss $ (47,918 ) $ (24,301 )Adjustments to reconcile net loss to net cash (used in) provided by operating activities:Impairment of goodwill 32,057 ? Depreciation, amortization of intangibles, debt 10,959 9,826 costs, and right-of-use assetsDeferred taxes (4,963 ) (7,070 )Stock-based compensation expense 1,306 1,787 Provision for expected credit losses 196 102 Net (loss) gain on disposal of property and equipment 22 (34 )held and used(Gain) loss on disposal of property and equipment (92 ) 6,005 related to restructuring, netChange in investment in non-public company, fair ? 11,800 valueOther, net (111 ) 21 Changes in current assets and current liabilities: Accounts receivable, net 4,541 9,559 Inventories (9,770 ) (4,891 )Prepaid expenses and other current assets (1,784 ) 1,539 Accounts payable 15,148 10,539 Accrued compensation (5,090 ) (1,345 )Other accrued liabilities 1,163 4,627 Deferred revenue 30 292 Net cash (used in) provided by operating activities (4,306 ) 18,456 Cash flows from investing activities: Sale of Investment in non-public company 45,100 ? Purchases of property and equipment (13,010 ) (7,407 )Proceeds from sales of fixed assets 1,082 12,885 Net cash provided by investing activities 33,172 5,478 Cash flows from financing activities: Payments on long-term debt (41,426 ) (20,062 )Proceeds from lines of credit 26,000 24,000 Payments on lines of credit (13,000 ) (24,400 )Payments for debt issuance costs (132 ) (1,237 )Taxes paid by Company for employee stock plans (512 ) (297 )Net cash used in financing activities (29,070 ) (21,996 )Net (decrease) increase in cash, cash equivalents and (204 ) 1,938 restricted cashCash and cash equivalents and restricted cash, 1,295 553 beginning of periodCash and cash equivalents and restricted cash, end of $ 1,091 $ 2,491 period Supplemental disclosure of non-cash investing and financing activities:Purchases of property and equipment on trade vendor $ 1,105 $ 1,526 credit

LANDEC CORPORATIONSEGMENT RESULTS(Unaudited and in thousands)

(Unaudited Three Months Ended Change Six Months Ended Changeand inthousands) November 28, November 29, November 28, November 29, 2021 2020 Amount % 2021 2020 Amount %

Revenues: Curation $ 104,546 $ 107,685 $ (3,139 ) (3 ) % $ 211,382 $ 221,523 $ (10,141 ) (5 ) %FoodsLifecore 24,946 23,219 1,727 7 % 46,898 45,024 1,874 4 %Total $ 129,492 $ 130,904 $ (1,412 ) (1 ) % $ 258,280 $ 266,547 $ (8,267 ) (3 ) %revenues Gross profit:Curation $ 1,277 $ 10,163 $ (8,886 ) (87 ) % $ 13,032 $ 21,507 $ (8,475 ) (39 ) %FoodsLifecore 11,715 10,474 1,241 12 % 17,479 15,476 2,003 13 %Totalgross $ 12,992 $ 20,637 $ (7,645 ) (37 ) % $ 30,511 $ 36,983 $ (6,472 ) (17 ) %profit Net (loss) income:Curation $ (33,239 ) $ (12,383 ) $ (20,856 ) (168 ) % $ (35,366 ) $ (20,654 ) $ (14,712 ) (71 ) %FoodsLifecore 5,682 4,492 1,190 26 % 6,262 4,604 1,658 36 %Other (10,884 ) (5,410 ) (5,474 ) (101 ) % (18,814 ) (8,251 ) (10,563 ) (128 ) %Total net $ (38,441 ) $ (13,301 ) $ (25,140 ) (189 ) % $ (47,918 ) $ (24,301 ) $ (23,617 ) (97 ) %loss EBITDA: Curation $ (38,826 ) $ (12,012 ) $ (26,814 ) (223 ) % $ (37,066 ) $ (18,110 ) $ (18,956 ) (105 ) %FoodsLifecore 9,130 7,271 1,859 26 % 11,421 8,727 2,694 31 %Other (2,023 ) (3,939 ) 1,916 49 % (5,009 ) (6,758 ) 1,749 26 %Total $ (31,719 ) $ (8,680 ) $ (23,039 ) (265 ) % $ (30,654 ) $ (16,141 ) $ (14,513 ) (90 ) %EBITDA

Pro Forma Financial Information:

On December 13, 2021 (the Closing Date), Landec Corporation (the Company or Landec) and its wholly owned subsidiary, Curation Foods, Inc. (Curation and together with the Company, the Sellers), and Taylor Farms Retail, Inc. (Taylor Farms and together with the Sellers, the Parties) completed the sale (the Eat Smart Disposition) of Curations Eat Smart business, including its salad and cut vegetable businesses (the Business), pursuant to the terms of an asset purchase agreement executed by the Parties on December 13, 2021 (the Asset Purchase Agreement). Pursuant to the Asset Purchase Agreement, Taylor acquired the Business for a purchase price of $73.5 million in cash, subject to a post-closing adjustment based upon net working capital at closing. As part of the Eat Smart Disposition, Taylor Farms acquired, among other assets related to the Business, the manufacturing facility and warehouses (and corresponding equipment) located in Bowling Green, Ohio and Guadalupe, California, as well as inventory, accounts receivable and accounts payable, intellectual property and information of the Business, and assumed certain executory obligations under the Companys and Curations outstanding contracts related to the Business, in each case, subject to the terms of the Asset Purchase Agreement. The following financial information reflects the results of Landec as adjusted on a pro forma basis to give effect to the Eat Smart Disposition.

The accompanying unaudited pro forma financial information was prepared utilizing our historical financial data derived from the interim consolidated financial statements included in our Quarterly Report on Form 10-Q for the period ended November 28, 2021, which will be filed with the Securities and Exchange Commission on January 7, 2022, and from the audited consolidated financial statements for the year ended May 30, 2021, included in our Annual Report on Form 10-K, which was filed with the Securities and Exchange Commission on July 29, 2021. The unaudited and consolidated schedules of operating (loss) income and adjusted segment results information for the three and six months ended November 28, 2021 and November 29, 2020 and the unaudited and condensed consolidated statement of operations and adjusted segment results information fiscal year ended May 30, 2021 assumes the transaction was consummated at June 1, 2020 (the first day of our fiscal year ended May 30, 2021), giving full effect to the transaction for the periods presented. The accompanying unaudited pro forma consolidated financial information should be read in conjunction with the Companys historical financial statements and risk factors included in its filings with the Securities and Exchange Commission.

The pro forma financial information contained in this press release was derived by adjusting the Companys consolidated financial statements and is based on estimates, available information and certain assumptions that the Companys management believes are reasonable. The Company's management believes that the adjustments provide a reasonable basis for presenting the significant effects of the transaction described above. The unaudited and consolidated pro forma financial information contained in this press release are for illustrative purposes only. The financial results may have been different had the sale actually taken place at the time indicated. You should not rely upon the unaudited and consolidated financial information as being indicative of the historical results that would have been achieved had the transaction occurred at the times indicated or of the future financial position or results the Company will experience.

LANDEC CORPORATIONCONSOLIDATED PRO FORMA SCHEDULES OF OPERATING (LOSS) INCOME(Unaudited and in thousands)

Three Months Ended November 28, 2021 Three Months Ended November 29, 2020 As Reported Pro Forma Pro Forma As Reported Pro Forma Pro Forma Adjustments AdjustmentsProduct sales $ 129,492 $ (86,040 ) $ 43,452 $ 130,904 $ (90,959 ) $ 39,945 Cost of 116,500 (87,763 ) 28,737 110,267 (83,923 ) 26,344 product salesGross profit 12,992 1,723 14,715 20,637 (7,036 ) 13,601 Operatingcosts and expenses:Research and 2,718 (862 ) 1,856 2,572 (806 ) 1,766 developmentSelling,general and 13,835 (5,824 ) 8,011 16,106 (6,792 ) 9,314 administrativeImpairment of 32,057 (32,057 ) ? ? ? ? goodwillLegalsettlement ? ? ? 1,763 ? 1,763 chargeRestructuring 1,412 (705 ) 707 1,662 (1,506 ) 156 costsTotaloperating 50,022 (39,448 ) 10,574 22,103 (9,104 ) 12,999 costs andexpensesOperating $ (37,030 ) $ 41,171 $ 4,141 $ (1,466 ) $ 2,068 $ 602 (loss) income

Six Months Ended November 28, 2021 Six Months Ended November 29, 2020 As Reported Pro Forma Pro As Reported Pro Forma Pro Forma Adjustments Forma AdjustmentsProduct sales $ 258,280 $ (173,196 ) $ 85,084 $ 266,547 $ (184,607 ) $ 81,940 Cost of 227,769 (167,835 ) 59,934 229,564 (169,073 ) 60,491 product salesGross profit 30,511 (5,361 ) 25,150 36,983 (15,534 ) 21,449 Operatingcosts and expenses:Research and 5,544 (1,815 ) 3,729 5,080 (1,400 ) 3,680 developmentSelling,general and 29,774 (12,292 ) 17,482 34,009 (14,174 ) 19,835 administrativeImpairment of 32,057 (32,057 ) ? ? ? ? goodwillLegalsettlement ? ? ? 1,763 ? 1,763 chargeRestructuring 3,974 (1,432 ) 2,542 10,066 (9,263 ) 803 costsTotaloperating 71,349 (47,596 ) 23,753 50,918 (24,837 ) 26,081 costs andexpensesOperating $ (40,838 ) $ 42,235 $ 1,397 $ (13,935 ) $ 9,303 $ (4,632 )(loss) income

LANDEC CORPORATIONUNAUDITED PRO FORMA CONSOLIDATED CONDENSED STATEMENT OF OPERATIONS(Unaudited and in thousands)

Twelve Months Ended May 30, 2021 As Reported Pro Forma Pro Forma AdjustmentsProduct sales $ 544,161 $ (372,615 ) $ 171,546 Cost of product sales 462,687 (341,612 ) 121,075 Gross profit 81,474 (31,003 ) 50,471 Operating costs and expenses: Research and development 10,222 (2,798 ) 7,424 Selling, general and 65,364 (27,074 ) 38,290 administrativeLegal settlement charge 1,763 ? 1,763 Restructuring costs 17,621 (15,738 ) 1,883 Total operating costs and 94,970 (45,610 ) 49,360 expensesOperating (loss) income (13,496 ) 14,607 1,111 Dividend Income 1,125 (1,125 ) ? Interest Income 48 ? 48 Interest expense, net (15,344 ) 4,957 (10,387 ) Loss on debt refinancing (1,110 ) ? (1,110 ) Other (expense) income, net (11,689 ) 11,800 111 Net loss before tax (40,466 ) 30,239 (10,227 ) Income tax benefit (expense) 7,801 (12,308 ) (4,507 ) Net loss $ (32,665 ) $ 17,931 $ (14,734 )

PRO FORMA ADJUSTED SEGMENT RESULTS:(Unaudited and in thousands)

Twelve Months Ended May 30, 2021 As Reported Pro Forma Adjustments Pro FormaRevenues: Curation Foods $ 446,074 $ (372,615 ) 73,459 Lifecore 98,087 ? 98,087 Total Revenues $ 544,161 $ (372,615 ) $ 171,546 Gross profit: Curation Foods $ 43,209 $ (31,003 ) 12,206 Lifecore 38,265 ? 38,265 Total Gross Profit $ 81,474 $ (31,003 ) $ 50,471 EBITDA: Curation Foods $ (20,373 ) $ 22,684 2,311 Lifecore 24,531 ? 24,531 Other (11,335 ) 2,427 (8,908 ) Total EBITDA $ (7,177 ) $ 25,111 $ 17,934

PRO FORMA ADJUSTED SEGMENT RESULTS:

(Unaudited Three Months Ended Change Six Months Ended Changeand inthousands) November 28, November 29, November 28, November 29, 2021 2020 Amount % 2021 2020 Amount %

Revenues: CurationFoods,segment $ 18,506 $ 16,726 $ 1,780 11 % $ 38,186 $ 36,916 $ 1,270 3 %pro formarevenueLifecore 24,946 23,219 1,727 7 % 46,898 45,024 1,874 4 %Total proforma $ 43,452 $ 39,945 $ 3,507 9 % $ 85,084 $ 81,940 $ 3,144 4 %revenues Gross profit:CurationFoods,segment $ 3,000 $ 3,127 $ (127 ) (4 ) % $ 7,671 $ 5,973 $ 1,698 28 %pro formagrossprofitLifecore 11,715 10,474 1,241 12 % 17,479 15,476 2,003 13 %Total proforma $ 14,715 $ 13,601 $ 1,114 8 % $ 25,150 $ 21,449 $ 3,701 17 %grossprofit EBITDA: CurationFoods,segment $ 807 $ 581 $ 226 39 % $ 2,620 $ 462 $ 2,158 467 %pro formaEBITDALifecore 9,130 7,271 1,859 26 % 11,421 8,727 2,694 31 %Other (3,032 ) (5,109 ) 2,077 41 % (7,223 ) (9,479 ) 2,256 24 %Total proforma $ 6,905 $ 2,743 $ 4,162 152 % $ 6,818 $ (290 ) $ 7,108 N/M EBITDA

(Unaudited Three Months Ended Six Months Endedand inthousands) November 28, November 29, November 28, November 29, 2021 2020 2021 2020

Revenues: CurationFoods, as $ 104,546 $ 107,685 $ 211,382 $ 221,523 reportedPro forma (86,040 ) (90,959 ) (173,196 ) (184,607 ) adjustmentsCurationFoods,segment pro $ 18,506 $ 16,726 $ 38,186 $ 36,916 formarevenues Gross profit:CurationFoods, as $ 1,277 $ 10,163 $ 13,032 $ 21,507 reportedPro forma 1,723 (7,036 ) (5,361 ) (15,534 ) adjustmentsCurationFoods,segment pro $ 3,000 $ 3,127 $ 7,671 $ 5,973 forma grossprofit EBITDA: CurationFoods, as $ (38,826 ) $ (12,012 ) $ (37,066 ) $ (18,110 ) reportedPro forma 39,633 12,593 39,686 18,572 adjustmentsCurationFoods,segment pro $ 807 $ 581 $ 2,620 $ 462 formaEBITDA

Non-GAAP Financial Information and Reconciliations

EBITDA and pro forma adjusted EBITDA are non-GAAP financial measures. We define EBITDA as earnings before interest expense, income tax expense (benefit), and depreciation and amortization. We define adjusted EBITDA as EBITDA before certain restructuring and other non-recurring charges and the fair market value change in Windset investment. We define pro forma adjusted EBITDA as EBITDA before certain restructuring and other non-recurring charges and after pro forma adjustments for the Eat Smart Disposition as discussed in the Pro Forma Financial Information section above. The table below presents the reconciliation of these non-GAAP financial measures to their respective most directly comparable financial measures calculated in accordance with GAAP and other supplemental information. See Non-GAAP Financial Information above for further information regarding the Companys use of non-GAAP financial measures.

(Unaudited and Three Months Ended Six Months Endedin thousands) November 28, November 29, November 28, November 29, 2021 2020 2021 2020Net loss $ (38,441 ) $ (13,301 ) $ (47,918 ) $ (24,301 ) Interestexpense, net of 4,314 3,029 12,204 6,130 interest incomeIncome tax (2,824 ) (2,700 ) (4,936 ) (7,009 ) benefitDepreciationand 5,232 4,292 9,996 9,039 amortizationTotal EBITDA (31,719 ) (8,680 ) (30,654 ) (16,141 ) Restructuringand other 2,104 5,590 5,462 16,161 non-recurringcharges (1)Impairment of 32,057 ? 32,057 ? goodwillFMV change inWindset ? 11,800 ? 11,800 investmentTotal Adjusted 2,442 8,710 6,865 11,820 EBITDAPro forma 5,862 (2,835 ) 3,980 (6,753 ) adjustmentsTotal pro forma $ 8,304 $ 5,875 $ 10,845 $ 5,067 adjusted EBITDA

(Unaudited and Curation Lifecore Other Totalin thousands) FoodsThree MonthsEnded November 28, 2021Net (loss) $ (33,239 ) $ 5,682 $ (10,884 ) $ (38,441 ) incomeInterestexpense, net of 1,376 (19 ) 2,957 4,314 interest incomeIncome tax(benefit) (10,496 ) 1,794 5,878 (2,824 ) expenseDepreciation and 3,533 1,673 26 5,232 amortizationTotal EBITDA (38,826 ) 9,130 (2,023 ) (31,719 ) Restructuringand other 703 ? 1,401 2,104 non-recurringcharges (1)Impairment of 32,057 ? ? 32,057 goodwillTotal Adjusted (6,066 ) 9,130 (622 ) 2,442 EBITDAPro forma 6,871 ? (1,009 ) 5,862 adjustmentsTotal pro forma $ 805 $ 9,130 $ (1,631 ) $ 8,304 adjusted EBITDA Six Months EndedNovember 28, 2021Net (loss) $ (35,366 ) $ 6,262 $ (18,814 ) $ (47,918 ) incomeInterestexpense, net of 2,752 (39 ) 9,491 12,204 interest incomeIncome tax(benefit) (11,176 ) 1,978 4,262 (4,936 ) expenseDepreciation and 6,724 3,220 52 9,996 amortizationTotal EBITDA (37,066 ) 11,421 (5,009 ) (30,654 ) Restructuringand other 1,899 ? 3,563 5,462 non-recurringcharges (1)Impairment of 32,057 ? ? 32,057 goodwillTotal Adjusted (3,110 ) 11,421 (1,446 ) 6,865 EBITDAPro forma 6,194 ? (2,214 ) 3,980 adjustmentsTotal pro forma $ 3,084 $ 11,421 $ (3,660 ) $ 10,845 adjusted EBITDA Three MonthsEnded November 29, 2020Net (loss) $ (12,383 ) $ 4,492 $ (5,410 ) $ (13,301 ) incomeInterestexpense, net of 1,376 ? 1,653 3,029 interest incomeIncome tax(benefit) (3,911 ) 1,419 (208 ) (2,700 ) expenseDepreciation and 2,906 1,360 26 4,292 amortizationTotal EBITDA (12,012 ) 7,271 (3,939 ) (8,680 ) Restructuringand other 2,591 ? 2,999 5,590 non-recurringcharges (1)FMV change inWindset 11,800 ? ? 11,800 investmentTotal Adjusted 2,379 7,271 (940 ) 8,710 EBITDAPro forma (1,664 ) ? (1,171 ) (2,835 ) adjustmentsTotal pro forma $ 715 $ 7,271 $ (2,111 ) $ 5,875 adjusted EBITDA Six Months EndedNovember 29, 2020Net (loss) $ (20,654 ) $ 4,604 $ (8,251 ) $ (24,301 ) incomeInterestexpense, net of 2,751 ? 3,379 6,130 interest incomeIncome tax(benefit) (6,523 ) 1,454 (1,940 ) (7,009 ) expenseDepreciation and 6,316 2,669 54 9,039 amortizationTotal EBITDA (18,110 ) 8,727 (6,758 ) (16,141 ) Restructuringand other 11,055 ? 5,106 16,161 non-recurringcharges (1)FMV change inWindset 11,800 ? ? 11,800 investmentTotal Adjusted 4,745 8,727 (1,652 ) 11,820 EBITDAPro forma (4,032 ) ? (2,721 ) (6,753 ) adjustmentsTotal pro forma $ 713 $ 8,727 $ (4,373 ) $ 5,067 adjusted EBITDA

(1)During fiscal year 2020, the Company announced a restructuring plan to drive enhanced profitability, focus the business on its strategic assets, and redesign the organization to be the appropriate size to compete and thrive. This included a reduction-in-force, a reduction in leased office spaces, and the sale of non-strategic assets. Related to these continued activities, in the second quarter of fiscal year 2022, the Company incurred (1) $1.4 million of restructuring charges ($4.0 million year to date), primarily related to consulting and legal costs and (2) $0.7 million ($1.5 million year to date) of certain non-recurring charges, primarily related to potential environmental and compliance matters at Curation Foods Avocado Products factory in Silao, Mexico, and other restructuring related legal and consulting costs.

Contact Information:Investor RelationsJeff Sonnek(646) 277-1263jeff.sonnek@icrinc.com